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Wash in rateAbstract Aim: Evaluation of diagnostic accuracy of dynamic contrast enhanced (DCE) MRI in
differentiating benign from malignant head and neck tumors using both Quantitative and semi
quantitative analysis.
Patients and methods: 55 patients with head and neck masses underwent DCEMRI at 1.5 T Philips
Ingenia MR scanner. Their enhancement curve patterns, Time to peak, wash in and washout rates
were analyzed and compared in benign and malignant tumors.
Results: 81.8% of benign tumors had gradual progressing and plateau curves, while 93.3% of
malignant tumors had plateau and fast curves. TTP, wash in and wash out rates were signiﬁcantly
different between benign and malignant tumors. Using TTP cut off value of 83.3 s differentiated
benign from malignant tumors with a sensitivity of 84.8% and speciﬁcity of 77.3%, while wash
in rate at cut off value of 15.4 1/s provided a sensitivity of 87.9% and speciﬁcity of 90.9%, wash
out rates provided at cut off value of 5.75 1/s, a sensitivity of 81.8% and speciﬁcity of 90.9%.
Conclusion: Dynamic contrast enhanced MRI is a promising method for differentiation between
benign and malignant head and neck tumors, wash in rate is the most speciﬁc parameter used.
 2015 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Head and neck cancer is common in several regions of the
world. Overall, head and neck cancer accounts for more than
550,000 cases annually worldwide (1).
Imaging has an important role in staging, planning treat-
ment and post-treatment follow up of patients with head and
neck cancer (2).ed.
Table 1 Shows histopathological entities of patients.
Histopathology No %
Benign Abscess 1 1.8
Inverted papilloma 3 5.5
Lymphoid hyperplasia 1 1.8
Neuroﬁbroma 1 1.8
Polyp 1 1.8
Angioﬁbroma 3 5.5
Dermoid cyst 1 1.8
Chondroma 2 3.6
Epidermoid 1 1.8
Vocal cord papilloma 1 1.8
Glomus vagale 1 1.8
Pleomorphic adenoma 4 7.2
Warthin tumor 2 3.6
Malignant Adenocarcinoma 3 5.5
Adenoid cystic carcinoma 4 7.3
Malignant ﬁbrous histiocytoma 1 1.8
Melanoma 1 1.8
Mucoepidermoid carcinoma 1 1.8
Ameloblastic ﬁbrosarcoma 1 1.8
Non hodgkin lymphoma 1 1.8
Olfactory neuroblastoma 1 1.8
Osteosarcoma 1 1.8
Papillary carcinoma 3 5.5
Anaplastic carcinoma 1 1.8
Chondrosarcoma 2 3.6
Squamous cell carcinoma 12 21.8
Fibrosarcoma 1 1.8
716 M. El Backry et al.Magnetic resonance imaging (MRI) is effective for diagnos-
ing tumors and has some advantages over other techniques,
especially in detecting soft tissue lesions. However, conven-
tional MRI is not able to differentiate normal highly vascular
structures, e.g. intrinsic tongue muscles and pharyngeal
mucosa from neoplasm, also not capable of determining
whether a tumor is benign or malignant. It has been reported
that dynamic contrast-enhanced MRI (DCE-MRI) is useful
for differentiating normal highly vascular structures from
neoplasm, allowing the investigator to determine the true
extent of a lesion, also it is helpful in differentiating tumors,
and many investigators have attempted to use it to identify dif-
ferences between benign and malignant tumors, as well as to
assess the malignancy of tumors (3).
So, head and neck imaging is shifting from the morpholog-
ical to the functional techniques as these techniques are used to
assess the complex interrelated processes in the cancer
microenvironment, such as hypoxia and angiogenesis (4).
Dynamic contrast enhanced magnetic resonance imaging
(DCE-MRI) is an important imaging technique used in
oncology assessment as it is able to identify changes in tissue
physiology.
A common approach in the analysis of DCE-MRI is
drawing (ROI) in region of interest and observes how the
average signal intensity of the ROI varies with time. It has
been reported that the time versus signal intensity curve, is
useful for differentiating head and neck tumors (5).
Although the semi quantitative evaluations have been
widely applied, they do not provide information on the under-
lying pharmacokinetic nature in the tissue. Moreover, an anal-
ysis based on the signal intensity (SI) is predominantly affected
by the scan parameters, and it is operator dependant (6).
So, there was also a need for a noninvasive quantitative
method which enables the quantiﬁcation of contrast agent
exchange between the intravascular and the interstitial space (7).
Few researches studied the role of either quantitative or
semi quantitative analysis in speciﬁc region in head and neck,
e.g. sinonasal (6), palate (8).
The aim of our study was to present an overview of diag-
nostic accuracy of DCE-MRI in differentiation between
benign and malignant head and neck tumors as a whole, and
to compare speciﬁcity and sensitivity of both quantitative
and semi quantitative analytical methods.2. Patients and methods
2.1. Patients
This prospective study included Fifty seven patients (with a
mean age of 44.84 ± 16.64 years); 38 males and 19 females
who underwent DCE-MRI, these patients came to our hospital
with head and neck masses between June 2012 and September
2014. They were referred from ENT, oncology center and
radiotherapy departments of Mansoura University Hospitals.
All patients underwent DCE-MRI as a part of routine post
contrast MRI study using Philips Ingenia 1.5 T. Two patients
were excluded from this study whose lesions were too small to
allow its signal intensity to be calculated. The ﬁnal diagnosis of
the masses was conﬁrmed by histopathological examination as
shown in Table 1. Thus, we ﬁnally evaluated 55 patients with
head and neck tumors.2.2. MRI protocol
Our study was performed on Philips Ingenia 1.5 T MRI scan-
ner in all of 55 cases, with the same scanning parameters. A
precontrast reference scan was ﬁrst performed through the
region of interest (ROI), and this was followed by routine head
and neck MR imaging protocol (axial 5 mm T2WI with fat
suppression and axial T1WI parallel to hard palate from skull
base to thoracic inlet, coronal and axial T1WI fat suppressed
image), then intravenous administration of gadolinium
(GD-DTPA).
T1-weighted image (600/20/2 [TR/TE/number of excita-
tions]; ﬁeld of view, 18 cm; matrix, 256 · 192; section thick-
ness, 2 mm; section gap, 1 mm) and fast spin-echo (fat
suppressed) T2-weighted image (4000/90/4; ﬁeld of view,
18 cm; matrix, 256 · 256; section thickness, 2 mm; section
gap, 1 mm) were obtained before the administration of con-
trast agent. A dynamic2D (axial T1WI fat suppressed) fast
spoiled gradient recalled sequence (10.4/2.3/1; ﬂip angle, 30;
ﬁeld of view, 18 cm; matrix, 256 · 128; section thickness,
4 mm; section gap, 1 mm) with total acquisition time of 240 s
during bolus injection (0.3 mmol/kg) of single dose contrast
agent gadopentetate dimeglumine (Magnevist) with a maxi-
mum dose of 30 ml at a rate of 2.5 ml/S given intravenously
via an automatic injector.
2.3. Image postprocessing
Multiphase dynamic images were analyzed using Philips
extended work space (EWS) release 2.6 workstation. We
placed a region of interest within an area of 10 mm2 (the area
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the tumors were avoided and this area showed the greatest
degree of early enhancement on the dynamic images). Time
signal intensity curve (TIC) after an injection of Gd-DTPA
in the ROI of each examination was plotted. The obtained
TICs were classiﬁed into four types on the basis of TTP peak
(the time to peak enhancement) into four types: type A
(gradual enhancement), type B (rapid enhancement and low
washout), type C (rapid enhancement and high washout),
and type D (ﬂat) (9).
Wash-in rate (K trans) is deﬁned as the rate of enhancement
between 10% and 90% of the signal intensity difference
between maximum signal intensity post-enhancement
(SImax) and signal intensity prior to enhancement (SIbase).
It was derived from the ﬁrst-pass phase of signal intensity
enhancement according to the following equation (10):
Wash in rate ¼ SImax  SIbaseð Þ  0:8½ 
SIbase  ðt90% t10%Þ½ 
 
 100
Wash-out rate (K ep) is the rate of monoexponential decay
of the enhancement signal in the tissue (i.e. vertebral body). It
was derived from the enhancement signal decay phase accord-
ing to the following equation:
y ¼ Span expðktÞ þ Plateau
where y refers to the MR signal (Y-axis values) and t refers
to time (X-axis values), Plateau refers to the MR signal value
when the contrast-enhancement decays to a plateau (10).1-Time to peak
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Fig. 1 ROC curves for TTP, was2.4. Image interpretation
Based on the ﬁndings on T1-weighted, T2-weighted, and post
contrast T1 fat suppressed images, dynamic contrast enhanced
MRI images were evaluated by two experienced head and neck
radiologists in consensus with 18 and 7 years of experience.
The region-of-interest (ROI) was placed in the solid part of
the lesion to avoid bias of low perfusion of the necrotic part.
The ROI was inserted using oval shaped function.
From this ROI, the time intensity curve and time to peak
value were automatically generated.
Quantitative analysis of the DCE-MRI data was automat-
ically performed using Philips extended work space (EWS)
release 2.6 workstation giving color maps and values of wash
in and wash out rates.
Semi quantitative and quantitative interpretations of the
DCE-MRI were done. Semi quantitative interpretation was
done using TIC and TTP.
Quantitative interpretation was done by measuring wash in
and wash out rate values.
2.5. Statistical analysis
Data are expressed as mean value ± SD for quantitative data
and as frequency (number-%) for qualitative data. Comparisons
were carried out by unpaired t test for parametric data. Inter-
group comparison of categorical data was performed by using
chi square test (X2-value). The sensitivity, speciﬁcity, positive2 - Wash in
Wash out 
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Fig. 2 Left maxillary squamous cell carcinoma in 44 years old male. (A) Axial T1 fat suppressed post contrast spin echo weighted image
shows intense enhancement. (B) TIC shows type C curve (gradual wash out). (C) TTP, wash in and wash out rates measures. (D) Wash in
rate. (E) Wash out rate.
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Fig. 3 Left sided sphenopalatine nasopharyngeal angioﬁbroma in a male patient aged 16 years. (A) Axial T1 fat suppressed post
contrast spin echo weighted image shows intensely enhancing mass. (B) TIC shows type A curve. (C) TTP, wash in and wash out rates
measures. (D) Wash in rate. (E) Wash out rate.
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Fig. 4 Warthin tumor of the left parotid gland of male patient aged 45 years. (A) Axial T1 spin echo fat suppressed post contrast
weighted image shows homogenous enhancement. (B) TIC shows type C curve (rapid wash out). (C) TTP, wash in and wash out rates
measures. (D) Wash in rate. (E) Wash out rate.
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Fig. 5 Melanoma of the right side of the nasal cavity of female patient aged 58 years. (A) Axial T1 spin echo fat suppressed post contrast
weighted image shows intense homogenous enhancement. (B) TIC shows type C curve (rapid wash out). (C) TTP, wash in and wash out
rates measures. (D) Wash in rate. (E) Wash out rate.
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Fig. 6 Malignant ﬁbrous histiocytoma in a male patient aged 12 years. (A) Axial T1 spin echo fat suppressed post contrast weighted
image shows small intramuscular lesion of intense homogenous enhancement. (B) TIC shows type C curve (rapid wash out). (C) TTP,
wash in and wash out rates measures. (D) Wash in rate. (E) Wash out rate.
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Fig. 7 Right vocal cord papilloma in a female patient aged 32 years. (A) Axial T1 fat suppressed post contrast spin echo weighted image
shows faintly enhancing mass. (B) TIC shows type A curve (gradual progressing curve). (C) TTP, wash in and wash out rates measures.
(D) Wash in rate. (E) Wash out rate.
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Table 2 Results of TICs analysis. p value > 0.05 is considered
signiﬁcant.
Groups p
Benign Malignant
No % No %
Type of curve A 7 31.8 1 3.0 0.01
B 11 50.0 8 24.2 0.2
C 2 9.1 23 69.7 0.004
D 2 9.1 1 3.0 0.6
Table 3 Results of mean value of TTP, wash in and wash out
rates. p value >0.05 is considered signiﬁcant.
Groups p
Benign Malignant
Mean ± SD Mean ± SD
Time to peak 101.19 ± 25.03 74.83 ± 16.83 <0.001
Wash in rate (1/s) 9.98 ± 4.78 18.95 ± 4.36 <0.001
Wash out rate (1/S) 2.11 ± 3.24 9.47 ± 4.08 <0.001
724 M. El Backry et al.predictive value, negative predictive value and accuracy of time to
peak, wash in and wash out to differentiate between benign and
malignant tumors were determined at different cutoff points using
ROC curve analysis to determine the best cutoff point as well as
the diagnostic power of each test. Differences were considered
statistically signiﬁcant when p< 0.05. Analysis was done using
SPSS for Windows (17.0 version) (see Fig. 1).
3. Results
Twenty-two patients had benign tumors, while remaining 33
had malignant tumors.
Of benign tumors 81.8% had types A (Figs. 3 and 7) and B
curves (31.8% and 50%) respectively, while 93.9% of malig-
nant tumors had types B and C (Figs. 2 and 4–6) curves
(24.2% and 69.7%) with signiﬁcant difference for curves A
and C for differentiation of benign and malignant tumors
(p= 0.01 and p= 0.004), no signiﬁcant difference for curves
B and D between benign and malignant tumors (p= 0.2 and
p= 0.6) (Table 2).
There was signiﬁcant difference in TTP between benign and
malignant tumors (Table 3). The results of ROC analysis of
TTP provided at cut off value of 83.3 s a sensitivity of
84.8% and speciﬁcity of 77.3% with an area under curve
(AUC) of 0.84 (Table 4).Table 4 Positive predictive values (PPV), negative predictive value
diagnosis of malignant tumors in the head and neck.
Area under the curve (95% CI) Cutoﬀ valu
Time to peak (s) 0.84(0.71–0.96) 83.3>
Wash in rate (1/s) 0.94(0.87–1.00) 15.4<
Wash out rate (1/s) 0.91(0.82–1.00) 5.75<There was signiﬁcant difference in wash in and wash out
rates between benign and malignant tumors (p< 0.001)
(Table 3). The results of ROC analysis of wash in rate at cut
off value of 15.4 1/s provided a sensitivity of 87.9% and
speciﬁcity of 90.9% with (AUC) of 0.94, those for wash out
rates provided at cut off value of 5.75 with (AUC) of 0.91, a
sensitivity of 81.8% and speciﬁcity of 90.9% for differentiation
of benign and malignant tumors (Table 4).
Warthin tumor shows type C curve and rapid wash out
rates than malignant tumors (Fig. 4).
4. Discussion
Conventional MRI helps in diagnosing head and neck tumors,
but differentiating benign from malignant moreover is still dif-
ﬁcult in many situations; hence, the physiologic properties of
lesions can be estimated by kinetic studies after contrast-med-
ium injection, we report in this study the utility of DCE-MRI
by two different analytical methods (semiquantitative and
quantitative) in differentiating benign and malignant tumors.
We ﬁrstly applied semi quantitative analysis by plotting SI
against time. The use of the TIC is the most conventional
method of assessing a DCE-MR study.
Sasaki et al. (11) used visual analysis and classiﬁcation of
TIC to differentiate between benign and malignant tumors as
in our study. While Ziech et al. (12) used it to investigate the
activity of inﬂammatory processes, while Lavini et al. (13)used
it to assess the effect of drugs.
The majority of the studies were done in the musculoskele-
tal system investigating bone, soft tissue tumors and inﬂamma-
tory processes (4,14,15).
Takashima et al. (16)classiﬁed the TIC of 79 head and neck
lesions into ﬁve groups according to the time at which they dis-
played peak enhancement: type A, the curve peaked at 0–30 s
after the administration of contrast medium; type B, the curve
peaked at 30–60 s after the administration of contrast medium;
type C, the curve peaked at 60–210 s after the administration
of contrast medium; type D, the curve displayed a gradual
upward slope; and type E, the curve was ﬂat.
Eida et al. (9) in agreement with us classiﬁed TIC into four
types: type A (gradual enhancement), type B (rapid enhance-
ment and low washout), type C (rapid enhancement and high
washout), and type D (ﬂat). In our study 81.8% of benign
tumors had types A and B curves (31.8% and 50% respec-
tively), while 93.9% of malignant tumors had types B and C
curves (24.2% and 69.7% respectively).
Study made by Sasaki et al. (17) on 44 patients with head
and neck tumors revealed that benign lesions present ﬂat,
gradual progressing and fast curves types (D, A and C) in
disagreement with our study, while malignant tumors contain
fast and plateau curves types (C and B) in agreement with the
present study.s (PPV), sensitivity and speciﬁcity of DCE-MRI features in the
e Sensitivity Speciﬁcity PPV NPV Accuracy
84.8 77.3 84.8 77.3 81.8
87.9 90.9 93.5 83.3 89.1
81.8 90.9 93.1 76.9 85.5
Role of DCE MR perfusion in differentiation 725The differences in types of curves happened between our
study and Sasaki et al. study could be explained by large num-
ber of warthin tumors contained in their study which gave type
C curve.
TTP in our study showed signiﬁcant difference between
benign and malignant tumors, giving mean value of 101.19 s
for benign tumors and 74.83 s for malignant tumors with cut
off value of 83.3 s at (AUC of 0.84) giving speciﬁcity of 77.3%
and sensitivity of 84.8%. These results were consistent with
Yabuuchi et al. (18) who studied TTP in 29 patients with salivary
gland tumors and concluded that TTP of 120 s enabled the dif-
ferentiation of pleomorphic adenomas from malignant tumors.
However the TIC shape analysis does not provide absolute
measures. It is dependent, affected by the length of the scan,
and the scan parameters (TR/ﬂip angle), all these factors can
inﬂuence the ﬁnal shape, resulting in the same tissue possibly
being classiﬁed differently when using different parameters (19).
In contrast to semi-quantitative techniques, intrinsic physio-
logic information of tissue microcirculation can be provided by
quantitative techniques which depend on contrast concentration
curves over time to observe the extravasation of contrast
agent from the vascular space to the interstitial space (20).
Pharmacokinetic modeling of the DCE-MRI signal is used to
calculate the kinetic parameters such as wash in and wash out
rates describing tumor and tissue permeability that are hallmarks
of the angiogenic phenotype associated with most cancers (21).
In the current study, we found signiﬁcant difference
(p< 0.001) as regards wash in and wash out rates between
benign and malignant tumors in agreement with Junfang
et al. (6), and the present study demonstrated mean value of
wash in rate was 9.98 1/s for benign tumors and 18.95 1/s for
malignant tumors, while mean value of wash out rate was
2.11 1/s for benign tumors and 9.47 1/s for malignant tumors.
Different studies on malignant tumors of the breast, pros-
tate, cervix, liver, lung, rectum, brain, and head and neck
reported that malignant tumors had higher wash in rate
(Ktrans) and washout rates (Kep) (20,22,23).
Although DCE-MRI is safe, non invasive, can be repeated
and performed on conventional MRI examination (19); how-
ever, there is some limitations to the routine clinical use of
DCE-MRI which is lack of standardized and optimized perfu-
sion MRI protocols, lacking of simple and standardized perfu-
sion postprocessing software and apparent complexity of
perfusion MRI for nonexpert radiologists (24).
5. Conclusion
We concluded that DCE-MRI plays a superior role to the con-
ventional MRI in differentiating benign from malignant head
and neck tumors.
Quantitative parameters improve the accuracy of DCE-
MRI by studying the tissue pharmacokinetics and tissue prop-
erties, and wash in rate was the best parameter used for differ-
entiation between benign and malignant tumors with cut off
value 15.4 1/s giving a sensitivity of 87.9% and speciﬁcity of
90.9% with (AUC) of 0.94.
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